Chemokines and Cancer

REFERENCES

• Clark-Lewis I., Schumacher C., Baggiolini M., Moser B. Structure–Activity Relationships of Interleukin-8 Determined Using Chemically Synthesized Analogs. Critical Role of NH2-Terminal Residues and Evidence for Uncoupling of Neutrophil Chemotaxis, Exocytosis, and Receptor Binding Activities. J. Biol. Chem. 1991; 266(34)23128–23134
   PubMed Web of Science ®Google Scholar
• Mantovani A. The Chemokine System: Redundancy for Robust Outputs. Immunol. Today 1999; 20(6)254–257
   PubMedGoogle Scholar
• Zlotnik A., Yoshie O. Chemokines: A New Classification System and Their Role in Immunity. Immunity 2000; 12(2)121–127
   PubMed Web of Science ®Google Scholar
• Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., Moser B. Chemokine Receptor Specific for IP10 and Mig: Structure, Function, and Expression in Activated T-Lymphocytes. J. Exp. Med. 1996; 184(3)963–969
   PubMed Web of Science ®Google Scholar
• Premack B.A., Schall T.J. Chemokine Receptors: Gateways to Inflammation and Infection. Nat. Med. 1996; 2(11)1174–1178
   PubMed Web of Science ®Google Scholar
• Laudanna C., Campbell J.J., Butcher E.C. Role of Rho in Chemoattractant-Activated Leukocyte Adhesion Through Integrins. Science 1996; 271(5251)981–983
   PubMed Web of Science ®Google Scholar
• Horuk R., Chitnis C.E., Darbonne W.C., Colby T.J., Rybicki A., Hadley T.J., Miller L.H. A Receptor for the Malarial Parasite Plasmodium Vivax: The Erythrocyte Chemokine Receptor. Science 1993; 261(5125)1182–1184
   PubMed Web of Science ®Google Scholar
• Ben Baruch A., Michiel D.F., Oppenheim J.J. Signals and Receptors Involved in Recruitment of Inflammatory Cells. J. Biol. Chem. 1995; 19;270(20)11703–11706
   Web of Science ®Google Scholar
• Cyster J.G. Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs. J. Exp. Med. 1999; 189(3)447–450
   PubMed Web of Science ®Google Scholar
• Luther S.A., Cyster J.G. Chemokines as Regulators of T Cell Differentiation. Nat. Immunol. 2001; 2: 102–107
   PubMed Web of Science ®Google Scholar
• Sallusto F. The Role of Chemokines and Chemokine Receptors in T Cell Priming and Th1/Th2-Mediated Responses. Haematologica 1999; 84: 28–31
   PubMedGoogle Scholar
• Banchereau J., Steinman R.M. Dendritic Cells and the Control of Immunity. Nature 1998; 392(6673)245–252
   PubMed Web of Science ®Google Scholar
• Sallusto F., Mackay C.R., Lanzavecchia A. The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses. Annu. Rev. Immunol. 2000; 18(5125)593–620
   PubMedGoogle Scholar
• Mohamadzadeh M., Poltorak A.N., Bergstressor P.R., Beutler B., Takashima A. Dendritic Cells Produce Macrophage Inflammatory Protein-1 Gamma, a New Member of the CC Chemokine Family. J. Immunol. 1996; 156(9)3102–3106
   PubMed Web of Science ®Google Scholar
• Biragyn A., Tani K., Grimm M.C., Weeks S., Kwak L.W. Genetic Fusion of Chemokines to a Self Tumor Antigen Induces Protective, T-Cell Dependent Antitumor Immunity. Nat. Biotechnol. 1999; 17(3)253–258
   PubMed Web of Science ®Google Scholar
• Smith G.L. Vaccinia Virus Immune Evasion. Immunol. Lett. 1999; 65(1–2)55–62
   PubMed Web of Science ®Google Scholar
• Boshoff C., Weiss R.A. Kaposi's Sarcoma-Associated Herpesvirus. Adv. Cancer Res. 1998; 75: 57–86
   PubMed Web of Science ®Google Scholar
• Murakami T., Yamamoto N. Roles of Chemokines and Chemokine Receptors in HIV-1 Infection. Int. J. Hematol. 2000; 72(4)412–417
   PubMed Web of Science ®Google Scholar
• Belperio J.A., Keane M.P., Arenberg D.A., Addison C.L., Ehlert J.E., Burdick M.D., Strieter R.M. CXC Chemokines in Angiogenesis. J. Leukoc. Biol. 2000; 68(1)1–8
   PubMed Web of Science ®Google Scholar
• Bar-Eli M. Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma. Pathobiology 1999; 67(1)12–18
   PubMed Web of Science ®Google Scholar
• Sgadari C., Angiolillo A.L., Cherney B.W., Pike S.E., Farber J.M., Koniaris L.G., Vanguri P., Burd P.R., Sheikh N., Gupta G., Teruya-Feldstein J., Tosato G. Interferon-Inducible Protein-10 Identified as a Mediator of Tumor Necrosis In Vivo. Proc. Natl Acad. Sci. USA 1996; 93(24)13791–13796
   PubMed Web of Science ®Google Scholar
• Wang J.M., Deng X., Gong W., Su S. Chemokines and Their Role in Tumor Growth and Metastasis. J. Immunol. Methods 1998; 220(1–2)1–17
   PubMed Web of Science ®Google Scholar
• Benomar A., Ming W.J., Taraboletti G., Ghezzi P., Balotta C., Cianciolo G.J., Snyderman R., Dore J.F., Mantovani A. Chemotactic Factor and P15E-Related Chemotaxis Inhibitor in Human Melanoma Cell Lines with Different Macrophage Content and Tumorigenicity in Nude Mice. J. Immunol. 1987; 138(7)2372–2379
   PubMed Web of Science ®Google Scholar
• Yoshimura T., Robinson E.A., Tanaka S., Appella E., Kuratsu J., Leonard E.J. Purification and Amino Acid Analysis of Two Human Glioma-Derived Monocyte Chemoattractants. J. Exp. Med. 1989; 169(4)1449–1459
   PubMed Web of Science ®Google Scholar
• Negus R.P., Stamp G.W., Hadley J., Balkwill F.R. Quantitative Assessment of the Leukocyte Infiltrate in Ovarian Cancer and Its Relationship to the Expression of C–C Chemokines. Am. J. Pathol. 1997; 150(5)1723–1734
   PubMed Web of Science ®Google Scholar
• Kunz M., Hartmann A., Flory E., Toksoy A., Koczan D., Thiesen H.J., Mukaida N., Neumann M., Rapp U.R., Brocker E.B., Gillitzer R. Anoxia-Induced Up-Regulation of Interleukin-8 in Human Malignant Melanoma. A Potential Mechanism for High Tumor Aggressiveness. Am. J. Pathol. 1999; 155(3)753–763
   PubMed Web of Science ®Google Scholar
• Compagni A., Christofori G. Recent Advances in Research on Multistage Tumorigenesis. Br. J. Cancer 2000; 83(1)1–5
   PubMed Web of Science ®Google Scholar
• Prest S.J., Rees R.C., Murdoch C., Marshall J.F., Cooper P.A., Bibby M., Li G., Ali S.A. Chemokines Induce the Cellular Migration of MCF-7 Human Breast Carcinoma Cells: Subpopulations of Tumour Cells Display Positive and Negative Chemotaxis and Differential In Vivo Growth Potentials. Clin. Exp. Metastasis 1999; 17(5)389–396
   PubMed Web of Science ®Google Scholar
• Wang J.M., Taraboletti G., Matsushima K., Van Damme J., Mantovani A. Induction of Haptotactic Migration of Melanoma Cells by Neutrophil Activating Protein/Interleukin-8. Biochem. Biophys. Res. Commun. 1990; 169(1)165–170
   PubMed Web of Science ®Google Scholar
• Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., Dzuiba J., Van Damme J., Walz A., Marriott D. The Functional Role of the ELR Motif in CXC Chemokine-Mediated Angiogenesis. J. Biol. Chem. 1995; 270(45)27348–27357
   PubMed Web of Science ®Google Scholar
• Arenberg D.A., Kunkel S.L., Polverini P.J., Morris S.B., Burdick M.D., Glass M.C., Taub D.T., Iannettoni M.D., Whyte R.I., Strieter R.M. Interferon-Gamma-Inducible Protein 10 (IP-10) Is an Angiostatic Factor That Inhibits Human Non-Small Cell Lung Cancer (NSCLC) Tumorigenesis and Spontaneous Metastases. J. Exp. Med. 1996; 184(3)981–992
   PubMed Web of Science ®Google Scholar
• Laning J., Kawasaki H., Tanaka E., Luo Y., Dorf M.E. Inhibition of In Vivo Tumor Growth by the Beta Chemokine TCA3. J. Immunol. 1994; 153(10)4625–4635
   PubMed Web of Science ®Google Scholar
• Mule J.J., Custer M., Averbook B., Yang J.C., Weber J.S., Goeddel D.V., Rosenberg S.A., Schall T.J. RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity In Vivo: Role of Immune Cell Subpopulations. Hum. Gene Ther. 1996; 7(13)1545–1553
   PubMed Web of Science ®Google Scholar
• Nakashima E., Oya A., Kubota Y., Kanada N., Matsushita R., Takeda K., Ichimura F., Kuno K., Mukaida N., Hirose K., Nakanishi I., Ujiie T., Matsushima K. A Candidate for Cancer Gene Therapy: MIP-1 Alpha Gene Transfer to an Adenocarcinoma Cell Line Reduced Tumorigenicity and Induced Protective Immunity in Immunocompetent Mice. Pharm. Res. 1996; 13(12)1896–1901
   PubMed Web of Science ®Google Scholar
• Braun S.E., Chen K., Foster R.G., Kim C.H., Hromas R., Kaplan M.H., Broxmeyer H.E., Cornetta K. The CC Chemokine CK Beta-11/MIP-3 Beta/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK Cells. J. Immunol. 2000; 164(8)4025–4031
   PubMed Web of Science ®Google Scholar
• Vicari A.P., Ait-Yahia S., Chemin K., Mueller A., Zlotnik A., Caux C. Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms. J. Immunol. 2000; 165(4)1992–2000
   PubMed Web of Science ®Google Scholar
• Mrowietz U., Schwenk U., Maune S., Bartels J., Kupper M., Fichtner I., Schroder J.M., Schadendorf D. The Chemokine RANTES Is Secreted by Human Melanoma Cells and Is Associated with Enhanced Tumour Formation in Nude Mice. Br. J. Cancer 1999; 79(7–8)1025–1031
   PubMed Web of Science ®Google Scholar
• Luboshits G., Shina S., Kaplan O., Engelberg S., Nass D., Lifshitz-Mercer B., Chaitchik S., Keydar I., Ben Baruch A. Elevated Expression of the CC Chemokine Regulated on Activation, Normal T Cell Expressed and Secreted (RANTES) in Advanced Breast Carcinoma. Cancer Res. 1999; 59(18)4681–4687
   PubMed Web of Science ®Google Scholar
• Mule J.J., Custer M., Averbook B., Yang J.C., Weber J.S., Goeddel D.V., Rosenberg S.A., Schall T.J. RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity In Vivo: Role of Immune Cell Subpopulations. Hum. Gene Ther. 1996; 7(13)1545–1553
   PubMed Web of Science ®Google Scholar
• Dilloo D., Bacon K., Holden W., Zhong W., Burdach S., Zlotnik A., Brenner M. Combined Chemokine and Cytokine Gene Transfer Enhances Antitumor Immunity. Nat. Med. 1996; 2(10)1090–1095
   PubMed Web of Science ®Google Scholar
• Narvaiza I., Mazzolini G., Barajas M., Duarte M., Zaratiegui M., Qian C., Melero I., Prieto J. Intratumoral Coinjection of Two Adenoviruses, One Encoding the Chemokine IFN-Gamma-Inducible Protein-10 and Another Encoding IL-12, Results in Marked Antitumoral Synergy. J. Immunol. 2000; 164(6)3112–3122
   PubMed Web of Science ®Google Scholar
• Dickman S. Antibodies Stage a Comeback in Cancer Treatment. Science 1998; 280(5367)1196–1197
   PubMed Web of Science ®Google Scholar
• Biragyn A., Tani K., Grimm M.C., Weeks S., Kwak L.W. Genetic Fusion of Chemokines to a Self Tumor Antigen Induces Protective, T-Cell Dependent Antitumor Immunity. Nat. Biotechnol. 1999; 17(3)253–258
   PubMed Web of Science ®Google Scholar
• Fushimi T., Kojima A., Moore M.A., Crystal R.G. Macrophage Inflammatory Protein 3alpha Transgene Attracts Dendritic Cells to Established Murine Tumors and Suppresses Tumor Growth. J. Clin. Investig. 2000; 105(10)1383–1393
   PubMed Web of Science ®Google Scholar
• Jolly D. Viral Vector Systems for Gene Therapy. Cancer Gene Ther. 1994; 1(1)51–64
   PubMed Web of Science ®Google Scholar
• Blaese M., Blankenstein T., Brenner M., Cohen-Haguenauer O., Gansbacher B., Russell S., Sorrentino B., Velu T. Vectors in Cancer Therapy: How Will They Deliver?. Cancer Gene Ther. 1995; 2(4)291–297
   PubMed Web of Science ®Google Scholar
• Horig H., Kaufman H.L. Current Issues in Cancer Vaccine Development. Clin. Immunol. 1999; 92(3)211–223
   PubMed Web of Science ®Google Scholar
• Flanagan, K.; Glover, R.; Soni, S.; Berman, J.; Hoerig, H.; Kaufman, H. Characterization of a Recombinant Vaccina Virus Expressing the Chemokine 6Ckine: A Method for Enhancing Cancer Vaccines (Abstract in: American Association for Cancer Research 91st annual meeting).
   Google Scholar